Prelude Therapeutics Incorporated - Common Stock —— 季度资产负债表 (NASDAQ:PRLD) | MetaTrader

展开完整图表完整图表

新闻

Wall Street Analysts Think Prelude Therapeutics (PRLD) Could Surge 33.59%: Read This Before Placing a Bet

Prelude Therapeutics提交文件拟通过Jefferies发行至多2500万美元股票

Prelude Therapeutics files to offer up to $25 million in stock through Jefferies

Citizens上调Prelude Therapeutics目标价,看好JAK2潜力

Citizens raises Prelude Therapeutics price target on JAK2 potential

Prelude Therapeutics股票获Citizens重申"市场表现优于大盘"评级

Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens

Prelude Therapeutics股价在FDA批准癌症药物IND申请后飙升

Prelude Therapeutics stock surges after FDA clears IND for cancer drug

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens

Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus